Taking aim - the oncology market looks to the nex generation of targeted cancer therapies

In this new age of cancer drugs, this is the biggest opportunity for Big Pharma, regulators, imbursement representatives, academia and biotech to discuss the challenges and opportunities for targeted therapy in the wake of an era of blockbusters.  

» Download the brochure
» Register today

• The World’s largest targeted cancer therapies congress tackling regulation,payment and partnership models: unique insights from key government bodies and global regulatory agencies on the next generation of oncology therapeutics.
   
• Over 30 sessions devoted to improving pre-clinical and early clinical development for the acceleration of products into the marketplace: strategic and scientific exchange concerning oncology biomarkers, diagnostics, target discovery and validation, pre-clinical models and clinical trial design.
   
• Unrivalled involvement from pharma and biotech with the biggest players in the oncology marketplace participating: Key representation from Roche, Novartis, Biogen Idec, ImClone Systems, Merck Serono, Merck & Co, Abbott Laboratories, Pfizer, AstraZeneca, Human Genome Sciences and many more…

5 Reasons to attend the strategic Oncology conference of the year!

 

1. Groundbreaking content tackles the
issues that matter: hear, learn, debate and act on the most critical scientific and business opportunities in the oncology sector

2. A speaker faculty comprising 100% regulatory, pharma, biotech and academics: an agenda packed with over 30 of the World’s leading experts in the targeted therapy and oncology fields

3. A proven track record – building on 5 years of 200+ delegate successful biologics conferences: from the team that bought you the European Antibody Congress and the World Stem Cells and Regenerative Medicine Congress

4. The one truly international industry
congress for oncology professionals: and a diverse agenda that covers all aspects of
targeted therapy for cancer

5. Unparalleled opportunities to build new business relationships: an attendee list that reads like the industry Who’s Who and over 12 hours of networking and 1-2-1 partnering opportunities

 

» Register your place today

 

Networking at the highest level 

 

Introducing you to your peers and your suppliers. ‘Contact’ is Terrapinn’s unique online introductory service. Don’t leave meeting key attendees to chance. Identify your partners of choice, contact them before the congress, engage onsite and followup post event.

 

Speed Networking is designed to quickly introduce you to half the congress attendees in one powerful 60 minute session, these meetings initiate contacts that often last well beyond the three days of the conference and blossom into fruitful and lasting business.

 

 This year's Targeted Cancer Therapies World Congress we will be hosting two evening drinks receptions following the conference programme on the 21st and 22nd of September. 

 

» Register now

AN UNRIVALLED SPEAKER  FACULTY INCLUDE:   REGULATION AND REIMBURSEMENT IN EUROPE

Jean-Jacques Garaud Head of Pharma Research & Early Development F. Hoffman-La Roche Dr Hagop Youssoufian CMO & Senior VP Global Clinical Sciences ImClone Systems, a wholly-owned subsidiary of Eli Lilly & Co Professor Jonas Bergh, Karolinska Institutet,   and University Hospital & School of Cancer & Imaging Sciences, University of Manchester, Medical Oncology Breast Unit, Christie Hospital, Scientific Advisory Group on Oncology, CMPH, EMEA IMPROVING PRE-CLINICAL & EARLY DEVELOPMENT Stafford O’Kelly President Molecular Diagnostics Abbott Laboratories Dr Hakan Sakul Senior Director & Global Head of Diagnostics Pfizer Dr Liliane Goetsch Head of Experimental Oncology Centre d’Immunologie Pierre Fabre CLINICAL TRIALS, COLLABORATION & COMBINATION THERAPY   Dr Jens-Oliver Funk Senior Vice President R&D, Global Therapeutic Head Merck Serono Dr Jeremy Barton Vice President Oncology R&D Biogen Idec Dr David Perry Vice President Global Clinical Development & Medical Affairs Baxter » See the full speaker list

Become a sponsor   

 

Sponsoring the Targeted Cancer Therapy World Congress  2010 will provide you with a globally attended marketing platform to clarify your offering to the industry, increase brand awareness and generate high quality face-to-face business meetings with your target audience.

» Request sponsor pack

» Download the event prospectus
 
If your company provides an opportunity to... 

• Enrich clinical trials with better pre-clinical models 
• Improve biomarker identification and diagnostic tools for cancer 
• Refine target identification and validation programmes 
• Produce innovative solutions for driving early R&D towards the clinic 
• Provide research and manufacturing resources for small molecules and biologics 
• Offer alternative options for the development of shelved-but-promising oncology candidates

…then you probably have the answers that big pharma is looking for!

 

For sponsorship opportunities call

Daniel Raines on +44 0 20 7092 1244 or email

daniel.raines@terrapinn.com

 

» Request sponsorship pack